• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Psychiatry

Shared decision-making tool for antidepressants improves patient and physician satisfaction

byAnees DaudandJames Jiang
September 29, 2015
in Psychiatry
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Amongst patients with moderate to severe depression being initiated on pharmacotherapy, using the shared decision-making tool, Depression Medication Choice, made patients and physicians feel greater comfort and empowerment compared to usual care.

2. However, the Depression Medication Choice had no significant effect on patient adherence or depression outcomes at the end of the 6-month follow-up period.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Depression is a very debilitating condition affecting a significant portion of the American population. The mainstay of treatment for moderate to severe depression is pharmacotherapy. However, not enough data exist on comparative effectiveness of these medications. More predictable, however, are some of the adverse effects. Both of these lead to difficulty with initiating and maintaining patients on appropriate therapy. This study was designed to determine whether a decision aid, Depression Medication Choice, could improve patient and physician experience, medication adherence, and outcomes. The results of the study showed that both the physicians and patients in the decision aid arm of the study felt more comfortable and empowered compared to the usual care group. However, the Depression Medication Choice had no significant effect on patient adherence or depression outcomes at the end of the six-month follow-up period.

The strength of the study was mainly in the design, applying the Depression Medication Choice in a randomized fashion. However, there was no blinding, so there is a significant risk of bias. Also, the results may not be generalizable since only a narrow geographic population was enrolled. Additionally, a 6-month follow-up period may not have been long enough for clinical outcomes differences to manifest.

Click to read the study, published today in JAMA Internal Medicine

RELATED REPORTS

Exercise is an effective alternative in the management of non-severe depression

#VisualAbstract: Pharmacogenomic testing in antidepressant selection for Major Depressive Disorder reduces prescription of medications with drug-gene interactions

Mirtazapine not effective in treating agitation in patients with dementia

Relevant Reading: Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study.

In-Depth [randomized controlled trial]: Ten primary care practices in Minnesota and Wisconsin were randomized to either Depression Medication Choice (DMC) or usual care (UC) – five in each group. The study took place from 2011 to 2013. The primary outcomes evaluated at six months were subjective quality of decision-making process from the patients’ and physicians’ perspective, patient adherence, and clinical outcomes (as determined by the PHQ-9).

At the end of the six months, the patients in the decision aid arm felt more comfortable with decision (p = 0.01) and felt more knowledgeable (p = 0.03). Similarly, the physicians in the decision aid arm felt more comfortable (p < 0.001) and were more satisfied (p = 0.02). However, there was no significant difference in the rate of adherence or differences in PHQ-9 scores at the six-month mark.

Image: CC/Wiki

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Antidepressant
Previous Post

Computer-aided detection not associated with improved accuracy in digital screening mammography

Next Post

Cognitive behavioral therapy effective for depression but not self-care in heart failure

RelatedReports

Few older adolescents meet recommended levels of physical activity
Chronic Disease

Exercise is an effective alternative in the management of non-severe depression

October 17, 2022
#VisualAbstract: Pharmacogenomic testing in antidepressant selection for Major Depressive Disorder reduces prescription of medications with drug-gene interactions
StudyGraphics

#VisualAbstract: Pharmacogenomic testing in antidepressant selection for Major Depressive Disorder reduces prescription of medications with drug-gene interactions

July 22, 2022
Quick Take: Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine
Chronic Disease

Mirtazapine not effective in treating agitation in patients with dementia

November 4, 2021
Children’s hospital visits for suicide ideation and attempts are increasing
Psychiatry

High Amplitude Low Frequency–Music Impulse Stimulation may decrease depressive symptoms in adults with mild-to-moderate depression

October 8, 2021
Next Post
Image-guided percutaneous drainage of pericardial effusions is safe and effective

Cognitive behavioral therapy effective for depression but not self-care in heart failure

Addressing non-obesity related barriers may improve bariatric surgery effectiveness

Bariatric surgery beneficial in type-2 diabetes, similar in cost to conventional treatment

Lung cancer screening may lower motivation for smoking cessation

Novel links identified between genetics, lung function and smoking behavior

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence based clinical decision systems are safe and effective for diabetes management
  • Epic Launchpad propels generative-AI into everyday hospital routines
  • #VisualAbstract: Routine Cerebral Embolic Protection Did Not Reduce Stroke Incidence during Transcatheter Aortic-Valve Implantation
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.